Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for WT1_MTF1_ZBTB7B
Z-value: 1.80
Motif logo
Transcription factors associated with WT1_MTF1_ZBTB7B
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
WT1
|
ENSG00000184937.8 | WT1 transcription factor |
|
MTF1
|
ENSG00000188786.9 | metal regulatory transcription factor 1 |
|
ZBTB7B
|
ENSG00000160685.9 | zinc finger and BTB domain containing 7B |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| WT1 | hg19_v2_chr11_-_32456891_32456906 | -0.88 | 3.0e-07 | Click! |
| MTF1 | hg19_v2_chr1_-_38325256_38325292 | 0.30 | 2.0e-01 | Click! |
| ZBTB7B | hg19_v2_chr1_+_154975110_154975149 | 0.30 | 2.0e-01 | Click! |
Activity profile of WT1_MTF1_ZBTB7B motif
Sorted Z-values of WT1_MTF1_ZBTB7B motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr3_-_185542817 | 11.36 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr3_-_185542761 | 10.59 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr22_+_17082732 | 8.25 |
ENST00000558085.2
ENST00000592918.1 ENST00000400593.2 ENST00000592107.1 ENST00000426585.1 ENST00000591299.1 |
TPTEP1
|
transmembrane phosphatase with tensin homology pseudogene 1 |
| chr12_-_28123206 | 7.93 |
ENST00000542963.1
ENST00000535992.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr16_+_56642489 | 7.33 |
ENST00000561491.1
|
MT2A
|
metallothionein 2A |
| chr2_-_1748214 | 7.32 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
| chr16_+_56659687 | 7.21 |
ENST00000568293.1
ENST00000330439.6 |
MT1E
|
metallothionein 1E |
| chr1_-_6321035 | 7.05 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
| chr9_-_21994597 | 7.04 |
ENST00000579755.1
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr9_-_21994344 | 6.96 |
ENST00000530628.2
ENST00000361570.3 |
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr2_+_10091815 | 6.65 |
ENST00000324907.9
|
GRHL1
|
grainyhead-like 1 (Drosophila) |
| chr12_-_28122980 | 6.51 |
ENST00000395868.3
ENST00000534890.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr13_-_20767037 | 6.27 |
ENST00000382848.4
|
GJB2
|
gap junction protein, beta 2, 26kDa |
| chr2_+_14772810 | 6.04 |
ENST00000295092.2
ENST00000331243.4 |
FAM84A
|
family with sequence similarity 84, member A |
| chr4_+_4388805 | 5.99 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
| chr19_-_12912657 | 5.99 |
ENST00000301522.2
|
PRDX2
|
peroxiredoxin 2 |
| chr4_+_1795012 | 5.88 |
ENST00000481110.2
ENST00000340107.4 ENST00000440486.2 ENST00000412135.2 |
FGFR3
|
fibroblast growth factor receptor 3 |
| chr17_+_81037473 | 5.78 |
ENST00000320095.7
|
METRNL
|
meteorin, glial cell differentiation regulator-like |
| chr2_-_46385 | 5.62 |
ENST00000327669.4
|
FAM110C
|
family with sequence similarity 110, member C |
| chr2_+_10091783 | 5.25 |
ENST00000324883.5
|
GRHL1
|
grainyhead-like 1 (Drosophila) |
| chr18_+_33877654 | 5.18 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr19_-_12912601 | 5.13 |
ENST00000334482.5
|
PRDX2
|
peroxiredoxin 2 |
| chr5_+_137801160 | 5.12 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
| chr15_-_83953466 | 5.00 |
ENST00000345382.2
|
BNC1
|
basonuclin 1 |
| chr3_-_13921594 | 4.95 |
ENST00000285018.4
|
WNT7A
|
wingless-type MMTV integration site family, member 7A |
| chr17_-_74582191 | 4.92 |
ENST00000225276.5
|
ST6GALNAC2
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
| chr8_-_10588010 | 4.87 |
ENST00000304501.1
|
SOX7
|
SRY (sex determining region Y)-box 7 |
| chr8_-_144952631 | 4.83 |
ENST00000525985.1
|
EPPK1
|
epiplakin 1 |
| chr5_+_131593364 | 4.76 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
| chr8_-_125740514 | 4.71 |
ENST00000325064.5
ENST00000518547.1 |
MTSS1
|
metastasis suppressor 1 |
| chr19_-_19051927 | 4.63 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
| chr1_-_6546001 | 4.50 |
ENST00000400913.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
| chr3_+_37903432 | 4.43 |
ENST00000443503.2
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
| chr4_-_819901 | 4.38 |
ENST00000304062.6
|
CPLX1
|
complexin 1 |
| chr11_-_12030629 | 4.36 |
ENST00000396505.2
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr4_-_819880 | 4.35 |
ENST00000505203.1
|
CPLX1
|
complexin 1 |
| chr6_-_13711773 | 4.33 |
ENST00000011619.3
|
RANBP9
|
RAN binding protein 9 |
| chr14_+_94640633 | 4.32 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr22_-_38794490 | 4.26 |
ENST00000400206.2
|
CSNK1E
|
casein kinase 1, epsilon |
| chr14_+_24867992 | 4.22 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
| chr19_-_12912688 | 4.21 |
ENST00000435703.1
|
PRDX2
|
peroxiredoxin 2 |
| chr1_-_95007193 | 4.17 |
ENST00000370207.4
ENST00000334047.7 |
F3
|
coagulation factor III (thromboplastin, tissue factor) |
| chr3_-_176915215 | 4.16 |
ENST00000457928.2
ENST00000422442.1 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
| chr14_+_94640671 | 4.16 |
ENST00000328839.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr20_+_57466461 | 4.13 |
ENST00000306090.10
|
GNAS
|
GNAS complex locus |
| chr11_+_46403303 | 4.11 |
ENST00000407067.1
ENST00000395565.1 |
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr8_-_11725549 | 4.10 |
ENST00000505496.2
ENST00000534636.1 ENST00000524500.1 ENST00000345125.3 ENST00000453527.2 ENST00000527215.2 ENST00000532392.1 ENST00000533455.1 ENST00000534510.1 ENST00000530640.2 ENST00000531089.1 ENST00000532656.2 ENST00000531502.1 ENST00000434271.1 ENST00000353047.6 |
CTSB
|
cathepsin B |
| chr1_-_182361327 | 4.08 |
ENST00000331872.6
ENST00000311223.5 |
GLUL
|
glutamate-ammonia ligase |
| chr15_+_69222827 | 4.01 |
ENST00000310673.3
ENST00000448182.3 ENST00000260364.5 |
SPESP1
NOX5
|
sperm equatorial segment protein 1 NADPH oxidase, EF-hand calcium binding domain 5 |
| chr5_-_2751762 | 3.99 |
ENST00000302057.5
ENST00000382611.6 |
IRX2
|
iroquois homeobox 2 |
| chr15_+_41136216 | 3.99 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr3_+_50192537 | 3.99 |
ENST00000002829.3
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr16_+_2564254 | 3.98 |
ENST00000565223.1
|
ATP6V0C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c |
| chr11_-_2906979 | 3.97 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
| chr3_+_50192499 | 3.96 |
ENST00000413852.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr1_-_11714700 | 3.94 |
ENST00000354287.4
|
FBXO2
|
F-box protein 2 |
| chr3_-_176914998 | 3.92 |
ENST00000431421.1
ENST00000422066.1 ENST00000413084.1 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
| chr1_-_182360498 | 3.91 |
ENST00000417584.2
|
GLUL
|
glutamate-ammonia ligase |
| chr6_+_30852738 | 3.91 |
ENST00000508312.1
ENST00000512336.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr19_-_2051223 | 3.90 |
ENST00000309340.7
ENST00000589534.1 ENST00000250896.3 ENST00000589509.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr1_+_44401479 | 3.89 |
ENST00000438616.3
|
ARTN
|
artemin |
| chr1_-_6479963 | 3.85 |
ENST00000377836.4
ENST00000487437.1 ENST00000489730.1 ENST00000377834.4 |
HES2
|
hes family bHLH transcription factor 2 |
| chr6_+_44095347 | 3.82 |
ENST00000323267.6
|
TMEM63B
|
transmembrane protein 63B |
| chr8_+_94929273 | 3.82 |
ENST00000518573.1
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
| chr5_+_9546306 | 3.82 |
ENST00000508179.1
|
SNHG18
|
small nucleolar RNA host gene 18 (non-protein coding) |
| chrX_+_134555863 | 3.77 |
ENST00000417443.2
|
LINC00086
|
long intergenic non-protein coding RNA 86 |
| chr4_-_119274121 | 3.76 |
ENST00000296498.3
|
PRSS12
|
protease, serine, 12 (neurotrypsin, motopsin) |
| chr1_-_182360918 | 3.75 |
ENST00000339526.4
|
GLUL
|
glutamate-ammonia ligase |
| chr20_+_36531499 | 3.75 |
ENST00000373458.3
ENST00000373461.4 ENST00000373459.4 |
VSTM2L
|
V-set and transmembrane domain containing 2 like |
| chr11_+_130029457 | 3.74 |
ENST00000278742.5
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma) |
| chr15_+_41136586 | 3.74 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr4_+_152330390 | 3.73 |
ENST00000503146.1
ENST00000435205.1 |
FAM160A1
|
family with sequence similarity 160, member A1 |
| chr11_+_369804 | 3.71 |
ENST00000329962.6
|
B4GALNT4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
| chr3_+_50192457 | 3.69 |
ENST00000414301.1
ENST00000450338.1 |
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr7_-_42276612 | 3.68 |
ENST00000395925.3
ENST00000437480.1 |
GLI3
|
GLI family zinc finger 3 |
| chr7_-_139876812 | 3.67 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
| chr3_+_50192833 | 3.66 |
ENST00000426511.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr12_-_29936731 | 3.63 |
ENST00000552618.1
ENST00000539277.1 ENST00000551659.1 |
TMTC1
|
transmembrane and tetratricopeptide repeat containing 1 |
| chr11_-_12030681 | 3.63 |
ENST00000529338.1
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr5_+_3596168 | 3.63 |
ENST00000302006.3
|
IRX1
|
iroquois homeobox 1 |
| chr8_+_94929168 | 3.62 |
ENST00000518107.1
ENST00000396200.3 |
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
| chr6_+_30852130 | 3.62 |
ENST00000428153.2
ENST00000376568.3 ENST00000452441.1 ENST00000515219.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chrX_+_102469997 | 3.59 |
ENST00000372695.5
ENST00000372691.3 |
BEX4
|
brain expressed, X-linked 4 |
| chr7_-_121036337 | 3.57 |
ENST00000426156.1
ENST00000359943.3 ENST00000412653.1 |
FAM3C
|
family with sequence similarity 3, member C |
| chr6_+_36098262 | 3.56 |
ENST00000373761.6
ENST00000373766.5 |
MAPK13
|
mitogen-activated protein kinase 13 |
| chr17_+_7255208 | 3.52 |
ENST00000333751.3
|
KCTD11
|
potassium channel tetramerization domain containing 11 |
| chr16_-_68269971 | 3.47 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
| chr19_+_11071685 | 3.46 |
ENST00000541122.2
ENST00000589677.1 ENST00000444061.3 |
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
| chr6_+_37137939 | 3.45 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
| chr11_+_46403194 | 3.42 |
ENST00000395569.4
ENST00000395566.4 |
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr15_+_101420028 | 3.41 |
ENST00000557963.1
ENST00000346623.6 |
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3 |
| chr19_+_11071652 | 3.40 |
ENST00000344626.4
ENST00000429416.3 |
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
| chr1_-_153538292 | 3.40 |
ENST00000497140.1
ENST00000368708.3 |
S100A2
|
S100 calcium binding protein A2 |
| chr17_-_74533963 | 3.39 |
ENST00000293230.5
|
CYGB
|
cytoglobin |
| chr19_+_13106383 | 3.38 |
ENST00000397661.2
|
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
| chr16_+_29817841 | 3.35 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr2_+_192542879 | 3.33 |
ENST00000409510.1
|
NABP1
|
nucleic acid binding protein 1 |
| chr22_+_33197683 | 3.33 |
ENST00000266085.6
|
TIMP3
|
TIMP metallopeptidase inhibitor 3 |
| chr18_-_28681950 | 3.31 |
ENST00000251081.6
|
DSC2
|
desmocollin 2 |
| chr16_-_56701933 | 3.30 |
ENST00000568675.1
ENST00000569500.1 ENST00000444837.2 ENST00000379811.3 |
MT1G
|
metallothionein 1G |
| chr22_+_45148432 | 3.30 |
ENST00000389774.2
ENST00000396119.2 ENST00000336963.4 ENST00000356099.6 ENST00000412433.1 |
ARHGAP8
|
Rho GTPase activating protein 8 |
| chr12_-_124457257 | 3.30 |
ENST00000545891.1
|
CCDC92
|
coiled-coil domain containing 92 |
| chr9_-_139440314 | 3.29 |
ENST00000277541.6
|
NOTCH1
|
notch 1 |
| chr1_-_6545502 | 3.27 |
ENST00000535355.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
| chr21_+_35445827 | 3.25 |
ENST00000608209.1
ENST00000381151.3 |
SLC5A3
SLC5A3
|
sodium/myo-inositol cotransporter solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
| chr3_-_126194707 | 3.25 |
ENST00000336332.5
ENST00000389709.3 |
ZXDC
|
ZXD family zinc finger C |
| chr1_+_6484829 | 3.24 |
ENST00000377828.1
|
ESPN
|
espin |
| chr8_+_124194752 | 3.22 |
ENST00000318462.6
|
FAM83A
|
family with sequence similarity 83, member A |
| chr14_+_102027688 | 3.21 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
| chrX_+_152953505 | 3.20 |
ENST00000253122.5
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8 |
| chr21_-_45196326 | 3.19 |
ENST00000291568.5
|
CSTB
|
cystatin B (stefin B) |
| chr15_+_41136369 | 3.18 |
ENST00000563656.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr17_-_7164410 | 3.17 |
ENST00000574070.1
|
CLDN7
|
claudin 7 |
| chr3_-_46735155 | 3.16 |
ENST00000318962.4
|
ALS2CL
|
ALS2 C-terminal like |
| chr4_-_77819002 | 3.16 |
ENST00000334306.2
|
SOWAHB
|
sosondowah ankyrin repeat domain family member B |
| chr17_-_7165662 | 3.15 |
ENST00000571881.2
ENST00000360325.7 |
CLDN7
|
claudin 7 |
| chr6_-_35464817 | 3.15 |
ENST00000338863.7
|
TEAD3
|
TEA domain family member 3 |
| chr7_-_98741642 | 3.13 |
ENST00000361368.2
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1 |
| chr16_+_68679193 | 3.12 |
ENST00000581171.1
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr20_+_57466629 | 3.10 |
ENST00000371081.1
ENST00000338783.6 |
GNAS
|
GNAS complex locus |
| chr15_-_74726283 | 3.09 |
ENST00000543145.2
|
SEMA7A
|
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) |
| chr15_+_31508174 | 3.09 |
ENST00000559292.2
ENST00000557928.1 |
RP11-16E12.1
|
RP11-16E12.1 |
| chr6_+_41606176 | 3.09 |
ENST00000441667.1
ENST00000230321.6 ENST00000373050.4 ENST00000446650.1 ENST00000435476.1 |
MDFI
|
MyoD family inhibitor |
| chr2_+_237476419 | 3.08 |
ENST00000447924.1
|
ACKR3
|
atypical chemokine receptor 3 |
| chr6_+_7541808 | 3.07 |
ENST00000379802.3
|
DSP
|
desmoplakin |
| chr6_+_43044003 | 3.07 |
ENST00000230419.4
ENST00000476760.1 ENST00000471863.1 ENST00000349241.2 ENST00000352931.2 ENST00000345201.2 |
PTK7
|
protein tyrosine kinase 7 |
| chr1_+_36789335 | 3.06 |
ENST00000373137.2
|
RP11-268J15.5
|
RP11-268J15.5 |
| chr3_-_124774802 | 3.05 |
ENST00000311127.4
|
HEG1
|
heart development protein with EGF-like domains 1 |
| chr5_+_9546376 | 3.04 |
ENST00000509788.1
|
SNHG18
|
small nucleolar RNA host gene 18 (non-protein coding) |
| chr9_-_21995300 | 3.02 |
ENST00000498628.2
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr6_+_37787704 | 3.02 |
ENST00000474522.1
|
ZFAND3
|
zinc finger, AN1-type domain 3 |
| chr19_+_11071546 | 3.02 |
ENST00000358026.2
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
| chr1_-_85358850 | 3.01 |
ENST00000370611.3
|
LPAR3
|
lysophosphatidic acid receptor 3 |
| chr11_-_568369 | 3.01 |
ENST00000534540.1
ENST00000528245.1 ENST00000500447.1 ENST00000533920.1 |
MIR210HG
|
MIR210 host gene (non-protein coding) |
| chr18_-_59561417 | 2.98 |
ENST00000591306.1
|
RNF152
|
ring finger protein 152 |
| chr7_-_143105941 | 2.98 |
ENST00000275815.3
|
EPHA1
|
EPH receptor A1 |
| chr21_-_40720974 | 2.98 |
ENST00000380748.1
|
HMGN1
|
high mobility group nucleosome binding domain 1 |
| chr3_-_176915036 | 2.97 |
ENST00000427349.1
ENST00000352800.5 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
| chr14_+_100070869 | 2.96 |
ENST00000502101.2
|
RP11-543C4.1
|
RP11-543C4.1 |
| chr4_+_2819883 | 2.96 |
ENST00000511747.1
ENST00000503393.2 |
SH3BP2
|
SH3-domain binding protein 2 |
| chr11_+_57365150 | 2.94 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
| chr7_-_143991230 | 2.93 |
ENST00000543357.1
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
| chr19_-_48673465 | 2.93 |
ENST00000598938.1
|
LIG1
|
ligase I, DNA, ATP-dependent |
| chr2_+_71693812 | 2.91 |
ENST00000409651.1
ENST00000394120.2 ENST00000409744.1 ENST00000409366.1 ENST00000410020.3 ENST00000410041.1 |
DYSF
|
dysferlin |
| chr16_+_56642041 | 2.90 |
ENST00000245185.5
|
MT2A
|
metallothionein 2A |
| chr16_-_2908155 | 2.89 |
ENST00000571228.1
ENST00000161006.3 |
PRSS22
|
protease, serine, 22 |
| chr1_-_22469459 | 2.88 |
ENST00000290167.6
|
WNT4
|
wingless-type MMTV integration site family, member 4 |
| chr11_+_129939811 | 2.87 |
ENST00000345598.5
ENST00000338167.5 |
APLP2
|
amyloid beta (A4) precursor-like protein 2 |
| chr19_+_45754505 | 2.87 |
ENST00000262891.4
ENST00000300843.4 |
MARK4
|
MAP/microtubule affinity-regulating kinase 4 |
| chr19_-_2050852 | 2.86 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr6_-_35464727 | 2.86 |
ENST00000402886.3
|
TEAD3
|
TEA domain family member 3 |
| chr22_+_38302285 | 2.85 |
ENST00000215957.6
|
MICALL1
|
MICAL-like 1 |
| chr11_-_64612041 | 2.85 |
ENST00000342711.5
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like) |
| chr7_-_127672146 | 2.84 |
ENST00000476782.1
|
LRRC4
|
leucine rich repeat containing 4 |
| chr1_+_205473720 | 2.84 |
ENST00000429964.2
ENST00000506784.1 ENST00000360066.2 |
CDK18
|
cyclin-dependent kinase 18 |
| chr19_+_8429031 | 2.83 |
ENST00000301455.2
ENST00000541807.1 ENST00000393962.2 |
ANGPTL4
|
angiopoietin-like 4 |
| chr3_+_41240925 | 2.82 |
ENST00000396183.3
ENST00000349496.5 ENST00000453024.1 |
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa |
| chr17_+_73717516 | 2.80 |
ENST00000200181.3
ENST00000339591.3 |
ITGB4
|
integrin, beta 4 |
| chr17_-_882966 | 2.80 |
ENST00000336868.3
|
NXN
|
nucleoredoxin |
| chr19_-_14228541 | 2.79 |
ENST00000590853.1
ENST00000308677.4 |
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha |
| chr16_-_80838160 | 2.78 |
ENST00000562812.1
ENST00000563890.1 ENST00000566173.1 |
CDYL2
|
chromodomain protein, Y-like 2 |
| chr7_+_90225796 | 2.78 |
ENST00000380050.3
|
CDK14
|
cyclin-dependent kinase 14 |
| chr12_-_95044309 | 2.78 |
ENST00000261226.4
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
| chr8_-_116680208 | 2.77 |
ENST00000517323.2
ENST00000520276.1 |
TRPS1
|
trichorhinophalangeal syndrome I |
| chr11_+_46402583 | 2.77 |
ENST00000359803.3
|
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr20_-_3219828 | 2.77 |
ENST00000539553.2
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11 |
| chr18_+_8609402 | 2.75 |
ENST00000329286.6
|
RAB12
|
RAB12, member RAS oncogene family |
| chr19_+_10713112 | 2.75 |
ENST00000590382.1
ENST00000407327.4 |
SLC44A2
|
solute carrier family 44 (choline transporter), member 2 |
| chr10_-_28591981 | 2.73 |
ENST00000445954.2
|
MPP7
|
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
| chr3_-_46735132 | 2.73 |
ENST00000415953.1
|
ALS2CL
|
ALS2 C-terminal like |
| chr17_-_43128943 | 2.71 |
ENST00000588499.1
ENST00000593094.1 |
DCAKD
|
dephospho-CoA kinase domain containing |
| chr8_+_94929077 | 2.71 |
ENST00000297598.4
ENST00000520614.1 |
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
| chr11_-_65640325 | 2.69 |
ENST00000307998.6
|
EFEMP2
|
EGF containing fibulin-like extracellular matrix protein 2 |
| chr4_+_1795508 | 2.69 |
ENST00000260795.2
ENST00000352904.1 |
FGFR3
|
fibroblast growth factor receptor 3 |
| chr1_+_35246775 | 2.69 |
ENST00000373366.2
|
GJB3
|
gap junction protein, beta 3, 31kDa |
| chr22_+_51112800 | 2.68 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
| chr2_+_192542850 | 2.68 |
ENST00000410026.2
|
NABP1
|
nucleic acid binding protein 1 |
| chr1_-_95285764 | 2.68 |
ENST00000414374.1
ENST00000421997.1 ENST00000418366.2 ENST00000452922.1 |
LINC01057
|
long intergenic non-protein coding RNA 1057 |
| chr9_-_21974820 | 2.68 |
ENST00000579122.1
ENST00000498124.1 |
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr2_+_181845298 | 2.68 |
ENST00000410062.4
|
UBE2E3
|
ubiquitin-conjugating enzyme E2E 3 |
| chr19_+_58570605 | 2.66 |
ENST00000359978.6
ENST00000401053.4 ENST00000439855.2 ENST00000313434.5 ENST00000511556.1 ENST00000506786.1 |
ZNF135
|
zinc finger protein 135 |
| chr20_+_35201993 | 2.66 |
ENST00000373872.4
|
TGIF2
|
TGFB-induced factor homeobox 2 |
| chr1_-_6550625 | 2.66 |
ENST00000377725.1
ENST00000340850.5 |
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
| chr8_-_57123815 | 2.65 |
ENST00000316981.3
ENST00000423799.2 ENST00000429357.2 |
PLAG1
|
pleiomorphic adenoma gene 1 |
| chr1_-_9189229 | 2.65 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
| chr16_+_2563871 | 2.65 |
ENST00000330398.4
ENST00000568562.1 ENST00000569317.1 |
ATP6V0C
ATP6C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c Uncharacterized protein |
| chr6_+_36097992 | 2.64 |
ENST00000211287.4
|
MAPK13
|
mitogen-activated protein kinase 13 |
| chrX_+_9754461 | 2.64 |
ENST00000380913.3
|
SHROOM2
|
shroom family member 2 |
| chr16_-_80838195 | 2.64 |
ENST00000570137.2
|
CDYL2
|
chromodomain protein, Y-like 2 |
| chr5_-_141257954 | 2.62 |
ENST00000456271.1
ENST00000394536.3 ENST00000503492.1 ENST00000287008.3 |
PCDH1
|
protocadherin 1 |
| chr1_+_13910194 | 2.62 |
ENST00000376057.4
ENST00000510906.1 |
PDPN
|
podoplanin |
| chr11_+_65554493 | 2.62 |
ENST00000335987.3
|
OVOL1
|
ovo-like zinc finger 1 |
| chr14_+_71108460 | 2.62 |
ENST00000256367.2
|
TTC9
|
tetratricopeptide repeat domain 9 |
| chr8_+_120220561 | 2.62 |
ENST00000276681.6
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene) |
| chr5_-_112630598 | 2.61 |
ENST00000302475.4
|
MCC
|
mutated in colorectal cancers |
| chr8_+_94929110 | 2.61 |
ENST00000520728.1
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
| chr3_-_52001448 | 2.61 |
ENST00000461554.1
ENST00000395013.3 ENST00000428823.2 ENST00000483411.1 ENST00000461544.1 ENST00000355852.2 |
PCBP4
|
poly(rC) binding protein 4 |
| chr11_-_65640071 | 2.60 |
ENST00000526624.1
|
EFEMP2
|
EGF containing fibulin-like extracellular matrix protein 2 |
| chr1_+_13910757 | 2.59 |
ENST00000376061.4
ENST00000513143.1 |
PDPN
|
podoplanin |
| chr3_+_133292851 | 2.58 |
ENST00000503932.1
|
CDV3
|
CDV3 homolog (mouse) |
Network of associatons between targets according to the STRING database.
First level regulatory network of WT1_MTF1_ZBTB7B
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 11.7 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 2.4 | 7.1 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 2.3 | 11.7 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 2.1 | 12.5 | GO:0030421 | defecation(GO:0030421) |
| 2.0 | 10.1 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 1.9 | 22.6 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 1.9 | 1.9 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 1.9 | 7.5 | GO:0060594 | mammary gland specification(GO:0060594) |
| 1.9 | 5.6 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 1.9 | 16.7 | GO:0032348 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 1.8 | 7.4 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 1.8 | 5.4 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 1.7 | 6.9 | GO:0051796 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 1.7 | 5.1 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
| 1.7 | 3.4 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 1.6 | 3.3 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 1.6 | 4.7 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 1.5 | 4.6 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 1.4 | 4.1 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
| 1.4 | 1.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 1.4 | 4.1 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 1.3 | 1.3 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
| 1.3 | 3.9 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 1.3 | 3.8 | GO:2000349 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 1.2 | 10.7 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 1.1 | 6.9 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 1.1 | 3.4 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 1.1 | 2.3 | GO:0019827 | stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
| 1.1 | 1.1 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
| 1.1 | 1.1 | GO:0061098 | regulation of protein tyrosine kinase activity(GO:0061097) positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 1.1 | 4.4 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 1.1 | 13.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 1.1 | 3.3 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 1.0 | 2.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) negative regulation of glucokinase activity(GO:0033132) regulation of hexokinase activity(GO:1903299) negative regulation of hexokinase activity(GO:1903300) |
| 1.0 | 5.1 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 1.0 | 6.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 1.0 | 4.0 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 1.0 | 3.0 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 1.0 | 5.0 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 1.0 | 3.0 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 1.0 | 6.9 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 1.0 | 2.9 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 1.0 | 2.9 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 1.0 | 2.9 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 1.0 | 2.9 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 1.0 | 3.8 | GO:0060166 | olfactory pit development(GO:0060166) |
| 1.0 | 4.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.0 | 9.6 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.9 | 7.5 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
| 0.9 | 6.5 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.9 | 1.9 | GO:0046066 | dGDP metabolic process(GO:0046066) |
| 0.9 | 3.7 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
| 0.9 | 4.6 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.9 | 2.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.9 | 4.6 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.9 | 1.8 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
| 0.9 | 3.6 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.9 | 2.7 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
| 0.9 | 2.6 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.9 | 2.6 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.9 | 5.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.8 | 2.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.8 | 2.5 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.8 | 4.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.8 | 2.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.8 | 2.5 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.8 | 5.0 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.8 | 31.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.8 | 0.8 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.8 | 4.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.8 | 7.2 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.8 | 0.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
| 0.8 | 11.8 | GO:0060613 | fat pad development(GO:0060613) |
| 0.8 | 2.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.8 | 0.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.8 | 5.4 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.8 | 4.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.8 | 0.8 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.8 | 3.0 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.7 | 1.5 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731) |
| 0.7 | 3.0 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.7 | 0.7 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
| 0.7 | 2.9 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.7 | 2.2 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.7 | 4.4 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.7 | 13.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.7 | 1.4 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.7 | 2.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.7 | 0.7 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.7 | 16.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.7 | 9.9 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.7 | 1.4 | GO:1905069 | allantois development(GO:1905069) |
| 0.7 | 2.8 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.7 | 2.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.7 | 4.8 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.7 | 2.8 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.7 | 7.6 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.7 | 3.4 | GO:0021557 | optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.7 | 2.0 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.7 | 2.7 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.7 | 6.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.7 | 1.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
| 0.7 | 5.9 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.7 | 2.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.7 | 3.9 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.7 | 3.9 | GO:1990834 | response to odorant(GO:1990834) |
| 0.6 | 1.9 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.6 | 3.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.6 | 1.9 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.6 | 3.2 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.6 | 1.9 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.6 | 2.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.6 | 1.3 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.6 | 1.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.6 | 3.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.6 | 3.1 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.6 | 1.9 | GO:0048627 | myoblast development(GO:0048627) |
| 0.6 | 0.6 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.6 | 2.5 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.6 | 3.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.6 | 1.8 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.6 | 1.2 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 0.6 | 0.6 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
| 0.6 | 1.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.6 | 1.8 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.6 | 5.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.6 | 1.8 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.6 | 0.6 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
| 0.6 | 1.2 | GO:0072034 | renal vesicle induction(GO:0072034) |
| 0.6 | 3.5 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.6 | 0.6 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.6 | 2.9 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.6 | 4.6 | GO:0030578 | PML body organization(GO:0030578) |
| 0.6 | 0.6 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.6 | 9.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.6 | 1.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.6 | 2.2 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.6 | 0.6 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.6 | 10.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.6 | 1.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.6 | 0.6 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.6 | 0.6 | GO:0090274 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.5 | 4.9 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.5 | 1.6 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.5 | 0.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.5 | 2.7 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.5 | 1.1 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.5 | 1.6 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.5 | 2.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.5 | 5.3 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.5 | 2.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.5 | 0.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
| 0.5 | 0.5 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
| 0.5 | 2.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.5 | 0.5 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.5 | 3.6 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.5 | 6.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.5 | 2.6 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.5 | 2.0 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 0.5 | 2.5 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.5 | 2.5 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.5 | 1.5 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.5 | 1.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
| 0.5 | 3.5 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.5 | 0.5 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.5 | 2.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.5 | 3.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.5 | 8.3 | GO:0035878 | nail development(GO:0035878) |
| 0.5 | 3.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.5 | 1.5 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.5 | 4.8 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
| 0.5 | 8.2 | GO:0015871 | choline transport(GO:0015871) |
| 0.5 | 7.2 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.5 | 1.0 | GO:0001300 | chronological cell aging(GO:0001300) |
| 0.5 | 1.0 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 0.5 | 0.5 | GO:1903008 | organelle disassembly(GO:1903008) |
| 0.5 | 3.8 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.5 | 2.3 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.5 | 2.3 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.5 | 1.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.5 | 1.4 | GO:2001201 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) regulation of transforming growth factor-beta secretion(GO:2001201) negative regulation of transforming growth factor-beta secretion(GO:2001202) |
| 0.5 | 3.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.5 | 1.4 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.5 | 1.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.5 | 1.4 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.5 | 0.9 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.5 | 1.8 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.5 | 4.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.5 | 1.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.4 | 6.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.4 | 1.8 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.4 | 1.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.4 | 2.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.4 | 2.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.4 | 1.8 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
| 0.4 | 1.8 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.4 | 4.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.4 | 1.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.4 | 8.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.4 | 7.4 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.4 | 3.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.4 | 10.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.4 | 4.3 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.4 | 4.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.4 | 1.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.4 | 6.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.4 | 1.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.4 | 1.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
| 0.4 | 0.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.4 | 5.1 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.4 | 1.7 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.4 | 1.3 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.4 | 2.5 | GO:1901909 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.4 | 1.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.4 | 2.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.4 | 0.8 | GO:0032796 | uropod organization(GO:0032796) |
| 0.4 | 1.2 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.4 | 0.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.4 | 1.2 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.4 | 1.2 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
| 0.4 | 0.4 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.4 | 0.8 | GO:0060425 | lung morphogenesis(GO:0060425) |
| 0.4 | 1.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
| 0.4 | 0.4 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.4 | 0.8 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.4 | 1.6 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.4 | 4.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.4 | 4.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.4 | 1.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.4 | 2.4 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.4 | 1.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.4 | 1.6 | GO:0009956 | radial pattern formation(GO:0009956) |
| 0.4 | 1.2 | GO:0021718 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.4 | 3.5 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.4 | 0.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.4 | 0.4 | GO:0051645 | Golgi localization(GO:0051645) |
| 0.4 | 1.2 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.4 | 0.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.4 | 4.6 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.4 | 1.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.4 | 1.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.4 | 3.4 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.4 | 5.0 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.4 | 0.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.4 | 1.5 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.4 | 1.9 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.4 | 3.0 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.4 | 0.4 | GO:0046959 | habituation(GO:0046959) |
| 0.4 | 0.8 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.4 | 1.5 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
| 0.4 | 9.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.4 | 0.7 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.4 | 1.1 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.4 | 1.1 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.4 | 0.7 | GO:1902232 | regulation of positive thymic T cell selection(GO:1902232) |
| 0.4 | 1.5 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.4 | 0.4 | GO:0031018 | endocrine pancreas development(GO:0031018) |
| 0.4 | 0.7 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.4 | 2.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.4 | 0.7 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.4 | 4.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.4 | 1.1 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.4 | 0.7 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.4 | 2.1 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.4 | 1.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.4 | 1.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.4 | 1.1 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.4 | 1.4 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.4 | 1.4 | GO:0060789 | hair follicle placode formation(GO:0060789) |
| 0.4 | 0.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.4 | 1.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.4 | 8.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.4 | 1.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.4 | 4.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.3 | 1.7 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.3 | 0.7 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.3 | 0.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.3 | 3.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.3 | 1.4 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.3 | 0.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.3 | 1.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 | 0.7 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.3 | 4.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.3 | 1.7 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.3 | 2.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.3 | 3.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 | 2.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.3 | 4.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.3 | 0.7 | GO:0032196 | transposition(GO:0032196) |
| 0.3 | 1.4 | GO:0032752 | response to molecule of fungal origin(GO:0002238) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) cellular response to molecule of fungal origin(GO:0071226) |
| 0.3 | 2.0 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.3 | 0.3 | GO:1902680 | positive regulation of RNA biosynthetic process(GO:1902680) |
| 0.3 | 4.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 3.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.3 | 0.3 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
| 0.3 | 14.0 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 0.3 | 1.0 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.3 | 1.3 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.3 | 0.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.3 | 1.0 | GO:1902565 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.3 | 5.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.3 | 4.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.3 | 0.3 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
| 0.3 | 1.6 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.3 | 2.6 | GO:0042471 | ear morphogenesis(GO:0042471) |
| 0.3 | 2.6 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.3 | 1.0 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.3 | 4.2 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.3 | 3.3 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.3 | 2.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.3 | 1.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.3 | 7.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.3 | 1.0 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
| 0.3 | 1.6 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.3 | 5.1 | GO:0015074 | DNA integration(GO:0015074) |
| 0.3 | 1.6 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.3 | 3.2 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.3 | 2.6 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.3 | 5.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.3 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.3 | 1.6 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.3 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.3 | 0.6 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.3 | 2.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.3 | 0.3 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.3 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.3 | 2.8 | GO:0072189 | ureter development(GO:0072189) |
| 0.3 | 1.6 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.3 | 1.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.3 | 0.6 | GO:0071806 | protein transmembrane transport(GO:0071806) |
| 0.3 | 1.2 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.3 | 0.9 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.3 | 5.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.3 | 4.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.3 | 0.6 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.3 | 2.2 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
| 0.3 | 6.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.3 | 0.6 | GO:0021603 | cranial nerve formation(GO:0021603) |
| 0.3 | 1.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.3 | 0.6 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.3 | 0.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.3 | 1.5 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
| 0.3 | 1.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.3 | 7.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.3 | 3.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.3 | 0.3 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.3 | 3.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.3 | 1.5 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.3 | 8.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.3 | 0.9 | GO:1901254 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.3 | 3.8 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
| 0.3 | 0.9 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.3 | 0.3 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.3 | 0.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.3 | 1.2 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.3 | 1.8 | GO:0006311 | meiotic gene conversion(GO:0006311) |
| 0.3 | 1.2 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.3 | 1.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.3 | 0.9 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.3 | 5.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.3 | 4.4 | GO:0046697 | decidualization(GO:0046697) |
| 0.3 | 0.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.3 | 0.6 | GO:0048320 | axial mesoderm formation(GO:0048320) |
| 0.3 | 1.2 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.3 | 2.3 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.3 | 2.8 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.3 | 7.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.3 | 2.3 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.3 | 0.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.3 | 0.6 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.3 | 5.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.3 | 0.8 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 | 0.8 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.3 | 1.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.3 | 0.6 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
| 0.3 | 2.5 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.3 | 4.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.3 | 3.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.3 | 0.3 | GO:0060629 | meiotic DNA double-strand break formation(GO:0042138) regulation of homologous chromosome segregation(GO:0060629) |
| 0.3 | 1.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.3 | 9.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.3 | 0.3 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.3 | 0.5 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
| 0.3 | 0.8 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.3 | 1.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.3 | 7.4 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.3 | 1.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.3 | 3.8 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
| 0.3 | 1.9 | GO:0030432 | peristalsis(GO:0030432) |
| 0.3 | 1.6 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.3 | 3.5 | GO:0015705 | iodide transport(GO:0015705) |
| 0.3 | 0.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.3 | 0.8 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.3 | 2.9 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.3 | 0.8 | GO:0050894 | determination of affect(GO:0050894) |
| 0.3 | 7.2 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 0.8 | GO:0072537 | fibroblast activation(GO:0072537) |
| 0.3 | 0.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.3 | 1.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.3 | 2.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.3 | 0.3 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.3 | 1.1 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 0.3 | 1.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 0.3 | 1.1 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.3 | 1.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.3 | 1.8 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.3 | 3.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.3 | 1.0 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.3 | 1.8 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.3 | 1.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.3 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.3 | 1.6 | GO:2000537 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.3 | 2.3 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.3 | 0.3 | GO:0032328 | alanine transport(GO:0032328) |
| 0.3 | 1.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.3 | 2.6 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.3 | 1.0 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.3 | 1.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.3 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.3 | 1.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.3 | 0.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.3 | 2.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 | 1.8 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.3 | 0.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.3 | 1.0 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.3 | 2.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 | 2.0 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.3 | 0.5 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
| 0.3 | 1.0 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.3 | 5.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 0.3 | 2.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.3 | 0.5 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
| 0.2 | 1.0 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.2 | 1.0 | GO:0072185 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
| 0.2 | 1.0 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 | 0.2 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
| 0.2 | 1.7 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.2 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
| 0.2 | 1.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
| 0.2 | 1.7 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.2 | 0.7 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.2 | 0.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.2 | 1.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 | 1.0 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.2 | 0.7 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.2 | 1.0 | GO:2000768 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.2 | 1.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.2 | 0.5 | GO:0031116 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
| 0.2 | 1.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.2 | 0.7 | GO:0030451 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 0.2 | 1.2 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
| 0.2 | 1.0 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.2 | 0.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.2 | 1.9 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.2 | 0.9 | GO:1904199 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.2 | 0.9 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.2 | 0.5 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.2 | 0.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.2 | 1.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 | 0.7 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
| 0.2 | 1.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.2 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.2 | 0.7 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.2 | 1.4 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.2 | 0.7 | GO:0071301 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.2 | 3.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.2 | 0.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 0.2 | 0.7 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.2 | 3.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.2 | 0.7 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.2 | 0.5 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.2 | 4.1 | GO:0045061 | thymic T cell selection(GO:0045061) |
| 0.2 | 2.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.2 | 4.1 | GO:0015816 | glycine transport(GO:0015816) |
| 0.2 | 0.5 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.2 | 0.2 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
| 0.2 | 0.7 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.2 | 0.2 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.2 | 1.4 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.2 | 2.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.2 | 1.1 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.2 | 2.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.2 | 1.4 | GO:0060180 | female mating behavior(GO:0060180) |
| 0.2 | 2.0 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 | 1.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.2 | 1.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.2 | 6.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 | 0.2 | GO:0060039 | pericardium development(GO:0060039) |
| 0.2 | 0.7 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.2 | 0.2 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.2 | 1.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.2 | 0.4 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.2 | 0.2 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.2 | 0.9 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.2 | 0.4 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.2 | 1.7 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.2 | 0.9 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
| 0.2 | 3.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.2 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.2 | 1.7 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.2 | 0.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 | 1.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.2 | 0.2 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.2 | 0.6 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.2 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.2 | 0.4 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.2 | 0.2 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.2 | 0.9 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 | 1.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 | 4.3 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.2 | 0.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.2 | 1.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.2 | 0.6 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 | 0.2 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
| 0.2 | 0.2 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
| 0.2 | 0.6 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 | 0.6 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 0.2 | 3.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.2 | 0.6 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.2 | 0.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 | 0.4 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 0.2 | 2.5 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.2 | 0.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.2 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.2 | 0.2 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.2 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
| 0.2 | 0.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 | 0.4 | GO:1903949 | positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.2 | 0.6 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.2 | 0.4 | GO:0060323 | head morphogenesis(GO:0060323) |
| 0.2 | 2.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.2 | 2.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.2 | 1.7 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.2 | 0.2 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
| 0.2 | 0.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.2 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.2 | 1.9 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.2 | 0.8 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.2 | 0.8 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.2 | 1.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
| 0.2 | 2.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.2 | 2.9 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.2 | 1.6 | GO:0070487 | monocyte aggregation(GO:0070487) |
| 0.2 | 2.0 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.2 | 6.1 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.2 | 1.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.2 | 2.0 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 | 0.6 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.2 | 0.6 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.2 | 0.8 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 0.2 | 0.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.2 | 0.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.2 | 0.6 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.2 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.2 | 0.6 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.2 | 0.2 | GO:0042119 | neutrophil activation(GO:0042119) |
| 0.2 | 0.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.2 | 0.4 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.2 | 1.4 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.2 | 1.0 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 | 0.4 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
| 0.2 | 0.8 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 | 1.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.2 | 1.0 | GO:0061055 | myotome development(GO:0061055) |
| 0.2 | 1.8 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.2 | 1.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.2 | 0.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 | 2.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 | 0.8 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.2 | 0.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.2 | 0.8 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.2 | 1.4 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 | 0.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.2 | 0.6 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.2 | 1.2 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.2 | 1.9 | GO:0097503 | sialylation(GO:0097503) |
| 0.2 | 2.1 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.2 | 3.5 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.2 | 2.3 | GO:0003360 | brainstem development(GO:0003360) |
| 0.2 | 3.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.2 | 2.3 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.2 | 1.0 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.2 | 0.6 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.2 | 1.1 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) positive regulation of blood vessel remodeling(GO:2000504) |
| 0.2 | 0.2 | GO:0061010 | gall bladder development(GO:0061010) |
| 0.2 | 0.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.2 | 0.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 | 5.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 0.6 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.2 | 0.8 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
| 0.2 | 3.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.2 | 0.4 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.2 | 1.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.2 | 2.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.2 | 8.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.2 | 1.1 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.2 | 0.6 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.2 | 0.6 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.2 | 0.9 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.2 | 2.9 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.2 | 0.7 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.2 | 8.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.2 | 0.7 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.2 | 1.5 | GO:0060051 | negative regulation of protein ADP-ribosylation(GO:0010836) negative regulation of protein glycosylation(GO:0060051) |
| 0.2 | 2.9 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 | 0.9 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.2 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.2 | 0.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.2 | 0.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.2 | 0.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 | 4.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.2 | 2.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.2 | 2.6 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.2 | 0.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.2 | 1.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.2 | 2.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.2 | 17.0 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.2 | 3.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.2 | 0.9 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.2 | 0.7 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 | 1.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.2 | 0.2 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.2 | 0.7 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.2 | 0.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.2 | 1.0 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
| 0.2 | 0.5 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
| 0.2 | 0.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.2 | 0.5 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.2 | 1.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.2 | 2.6 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.2 | 0.5 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.2 | 0.5 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.2 | 1.2 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.2 | 0.9 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.2 | 0.7 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.2 | 1.4 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.2 | 0.9 | GO:0048749 | compound eye development(GO:0048749) |
| 0.2 | 1.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.2 | 0.5 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.2 | 8.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 | 0.5 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.2 | 0.7 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.2 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.2 | 0.5 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.2 | 0.7 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
| 0.2 | 0.3 | GO:0097477 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.2 | 1.8 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
| 0.2 | 0.8 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.2 | 0.7 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.2 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.2 | 0.5 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.2 | 0.5 | GO:1903513 | endoplasmic reticulum to cytosol transport(GO:1903513) |
| 0.2 | 1.8 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.2 | 0.3 | GO:0015800 | acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
| 0.2 | 0.3 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.2 | 0.7 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.2 | 0.3 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
| 0.2 | 1.0 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 | 1.3 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.2 | 0.8 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.2 | 1.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.2 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.2 | 0.5 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.2 | 1.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.2 | 2.9 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.2 | 0.8 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.2 | 1.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.2 | 0.8 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.2 | 0.6 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.2 | 0.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.2 | 1.6 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 | 0.5 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.2 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.2 | 1.1 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.2 | 0.8 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.2 | 5.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.2 | 1.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.2 | 0.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 | 3.6 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
| 0.2 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.2 | 2.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.2 | 0.6 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.2 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 | 1.2 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
| 0.2 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.2 | 1.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.2 | 0.6 | GO:0048511 | rhythmic process(GO:0048511) |
| 0.2 | 0.8 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.2 | 0.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
| 0.2 | 0.2 | GO:0007632 | visual behavior(GO:0007632) |
| 0.2 | 0.8 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.2 | 1.7 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
| 0.2 | 3.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 | 1.8 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.2 | 1.2 | GO:2001197 | positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.2 | 0.8 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.2 | 0.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 | 0.3 | GO:0031016 | pancreas development(GO:0031016) |
| 0.1 | 2.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.1 | 1.2 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 1.2 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.1 | 1.6 | GO:0042428 | serotonin metabolic process(GO:0042428) |
| 0.1 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.4 | GO:0008291 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) acetylcholine metabolic process(GO:0008291) negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) acetate ester metabolic process(GO:1900619) |
| 0.1 | 0.4 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 | 0.4 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.1 | 0.1 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) positive regulation of mast cell cytokine production(GO:0032765) |
| 0.1 | 0.6 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 | 0.4 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.1 | 0.3 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.1 | 1.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 | 0.3 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
| 0.1 | 2.2 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 | 3.9 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 | 1.3 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.1 | 0.7 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
| 0.1 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 | 3.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.1 | 0.4 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.1 | 2.9 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 | 0.1 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.1 | 0.6 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
| 0.1 | 2.4 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 0.1 | 0.3 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.1 | 0.6 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
| 0.1 | 0.4 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 0.1 | 1.1 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 0.4 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 | 0.8 | GO:0048747 | muscle fiber development(GO:0048747) |
| 0.1 | 0.8 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 | 0.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 | 0.4 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.1 | 0.7 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 1.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.1 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.1 | 0.3 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.1 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 | 4.8 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.1 | 0.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 0.5 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
| 0.1 | 1.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 | 0.7 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 | 0.7 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.5 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.1 | 0.1 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.1 | 0.7 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 | 0.4 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
| 0.1 | 3.9 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.1 | 0.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.1 | 0.3 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.1 | 0.4 | GO:0035349 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.1 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.1 | 0.8 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 | 0.1 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
| 0.1 | 0.5 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 0.1 | 1.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.1 | 0.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 | 0.4 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.1 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.1 | 2.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 0.5 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 | 1.2 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.1 | 0.9 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 0.1 | GO:0098917 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
| 0.1 | 2.3 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
| 0.1 | 0.6 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.1 | 1.0 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.1 | 0.5 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
| 0.1 | 0.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 | 1.3 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 | 0.9 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.1 | 0.4 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.1 | 0.4 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
| 0.1 | 0.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 | 1.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.1 | 0.9 | GO:0097647 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 | 1.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 1.4 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
| 0.1 | 1.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.1 | 0.5 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.1 | 1.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 | 0.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 0.1 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.1 | 1.6 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
| 0.1 | 0.2 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
| 0.1 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 | 1.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.1 | 3.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 1.0 | GO:0032439 | endosome localization(GO:0032439) |
| 0.1 | 0.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 | 0.7 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 | 0.7 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.1 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.1 | 0.5 | GO:2000553 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.1 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 2.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.1 | 0.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 | 0.4 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.1 | 0.7 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.1 | 0.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 | 0.2 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.1 | 0.7 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.1 | 0.5 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.1 | 2.4 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.1 | 1.4 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 | 0.5 | GO:0038001 | paracrine signaling(GO:0038001) |
| 0.1 | 0.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.1 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 | 2.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.1 | 2.9 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.1 | 0.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 0.3 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 0.1 | 2.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 1.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 0.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 0.8 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 | 0.9 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 0.3 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.1 | 5.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.1 | 0.3 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.1 | 1.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.1 | 0.9 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
| 0.1 | 0.2 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.1 | 0.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.1 | 0.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.1 | 1.4 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.1 | 0.7 | GO:0072077 | renal vesicle formation(GO:0072033) renal vesicle morphogenesis(GO:0072077) |
| 0.1 | 1.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.1 | 0.4 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 | 0.4 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.1 | 1.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 0.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 | 0.2 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
| 0.1 | 0.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.1 | 0.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.4 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.1 | 0.7 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 | 0.2 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
| 0.1 | 1.4 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.1 | 0.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.1 | 0.6 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
| 0.1 | 2.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 | 1.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 1.5 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.1 | 3.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.1 | 0.3 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 0.1 | 2.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 5.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 1.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.1 | 0.1 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
| 0.1 | 0.4 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.1 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
| 0.1 | 0.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.1 | 1.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 0.7 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.1 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.1 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 | 1.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.1 | 2.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 1.0 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 0.9 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.1 | 2.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 4.5 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 | 1.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.1 | 0.2 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.1 | 0.3 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 1.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 0.2 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
| 0.1 | 2.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.1 | 0.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.1 | 0.3 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) DNA dephosphorylation(GO:0098502) |
| 0.1 | 0.2 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.1 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.1 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.1 | 1.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.1 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.1 | 0.5 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.1 | 1.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 0.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.1 | 0.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 | 0.7 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 | 0.1 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
| 0.1 | 0.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.1 | 1.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.1 | 0.3 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.1 | 0.5 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
| 0.1 | 0.1 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.1 | 0.8 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 | 0.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 | 1.0 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
| 0.1 | 1.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.1 | 0.1 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
| 0.1 | 1.0 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
| 0.1 | 0.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.1 | 0.9 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.1 | 0.1 | GO:0060374 | mast cell differentiation(GO:0060374) |
| 0.1 | 0.4 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.1 | 0.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.1 | 0.5 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.1 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 | 0.2 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 0.1 | 0.3 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 | 6.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.8 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.1 | 0.7 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 | 1.0 | GO:0034333 | adherens junction assembly(GO:0034333) |
| 0.1 | 0.4 | GO:0051836 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.1 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
| 0.1 | 0.3 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.1 | 1.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.1 | 0.3 | GO:0071048 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.1 | 0.1 | GO:0000393 | generation of catalytic spliceosome for first transesterification step(GO:0000349) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
| 0.1 | 0.1 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 0.1 | 0.7 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
| 0.1 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.1 | 1.9 | GO:0002385 | mucosal immune response(GO:0002385) |
| 0.1 | 0.4 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 1.7 | GO:1903391 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) regulation of adherens junction organization(GO:1903391) |
| 0.1 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.1 | 0.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.1 | 0.6 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 | 1.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 1.9 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.1 | 6.0 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 | 0.4 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.1 | 0.5 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 | 0.9 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 | 0.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 | 0.2 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.1 | 0.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 0.8 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.1 | 0.9 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.1 | 0.3 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 | 0.2 | GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) adenosine biosynthetic process(GO:0046086) |
| 0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
| 0.1 | 0.6 | GO:0060349 | bone morphogenesis(GO:0060349) |
| 0.1 | 0.4 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.1 | 0.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 0.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.1 | 0.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.1 | 0.7 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
| 0.1 | 0.6 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 0.1 | 0.2 | GO:0045066 | regulatory T cell differentiation(GO:0045066) regulation of regulatory T cell differentiation(GO:0045589) |
| 0.1 | 0.3 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
| 0.1 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.1 | 0.6 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 1.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 0.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 | 0.4 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
| 0.1 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.1 | 0.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.1 | 0.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.1 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.1 | 0.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 | 0.1 | GO:0001942 | hair follicle development(GO:0001942) |
| 0.1 | 0.7 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 | 0.2 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.1 | 1.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.5 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.1 | 0.4 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.1 | 0.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 0.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 0.6 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.1 | 0.1 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
| 0.1 | 1.2 | GO:0042554 | superoxide anion generation(GO:0042554) |
| 0.1 | 0.2 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 | 1.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 0.2 | GO:0010193 | response to ozone(GO:0010193) |
| 0.1 | 0.2 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.1 | 0.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.1 | 1.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 0.5 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
| 0.1 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.1 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 0.9 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.1 | 2.4 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.1 | 0.5 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 | 1.5 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
| 0.1 | 0.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 | 0.1 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
| 0.1 | 0.4 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 | 0.2 | GO:0050810 | regulation of steroid biosynthetic process(GO:0050810) |
| 0.1 | 1.0 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 0.1 | 0.2 | GO:0042311 | vasodilation(GO:0042311) |
| 0.1 | 2.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.1 | 0.3 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 1.6 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
| 0.1 | 0.1 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
| 0.1 | 0.5 | GO:0008334 | histone mRNA metabolic process(GO:0008334) histone mRNA catabolic process(GO:0071044) |
| 0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
| 0.1 | 1.3 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.1 | 1.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 0.2 | GO:1990910 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.1 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 | 0.4 | GO:1905214 | regulation of RNA binding(GO:1905214) |
| 0.1 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 | 1.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.1 | 0.9 | GO:0045187 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.1 | 0.7 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 0.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.1 | 0.6 | GO:0071514 | genetic imprinting(GO:0071514) |
| 0.1 | 1.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 | 0.7 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.1 | 0.3 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 | 0.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.1 | 0.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 | 0.3 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 0.4 | GO:0001705 | ectoderm formation(GO:0001705) |
| 0.1 | 0.1 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.1 | 0.1 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.1 | 0.2 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
| 0.1 | 0.7 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 | 0.1 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 | 0.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.1 | 0.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.1 | 0.4 | GO:0035315 | hair cell differentiation(GO:0035315) |
| 0.1 | 0.2 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
| 0.1 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 | 4.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.5 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.1 | 0.3 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.1 | 0.4 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.1 | 1.5 | GO:0003341 | cilium movement(GO:0003341) |
| 0.1 | 0.1 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
| 0.1 | 1.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.1 | 1.5 | GO:0045861 | negative regulation of proteolysis(GO:0045861) |
| 0.1 | 0.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.1 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 | 0.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 0.1 | 0.4 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.1 | 0.7 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 0.1 | 0.4 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 | 0.8 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.1 | 0.5 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 | 0.3 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 | 0.8 | GO:0036065 | fucosylation(GO:0036065) |
| 0.1 | 0.1 | GO:0030540 | female genitalia development(GO:0030540) neutrophil clearance(GO:0097350) |
| 0.1 | 0.2 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.1 | 0.3 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.1 | 0.2 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
| 0.1 | 0.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 | 4.3 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.1 | 1.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.1 | 0.4 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.1 | 0.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
| 0.1 | 0.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.1 | 0.8 | GO:0032570 | response to progesterone(GO:0032570) |
| 0.1 | 0.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.1 | 0.2 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) |
| 0.1 | 0.5 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 0.2 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
| 0.1 | 0.8 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.1 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.1 | 3.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.1 | 0.2 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.1 | 1.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.1 | 0.4 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
| 0.1 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 | 1.5 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 | 0.7 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 | 0.3 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 | 4.4 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
| 0.1 | 0.4 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.1 | 0.4 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 | 1.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 0.1 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
| 0.1 | 0.3 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.1 | 10.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.1 | 0.8 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
| 0.1 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.1 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 0.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.1 | 0.2 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.1 | 0.1 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
| 0.1 | 0.9 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.1 | 0.8 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.1 | 0.1 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
| 0.1 | 0.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.1 | 0.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.1 | 0.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 0.1 | 0.3 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 | 0.3 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 | 2.4 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.1 | 0.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.1 | 0.1 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.1 | 0.2 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.1 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 | 0.4 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.1 | 0.3 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
| 0.1 | 0.3 | GO:0070555 | response to interleukin-1(GO:0070555) |
| 0.1 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 | 0.5 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
| 0.1 | 0.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.1 | 0.2 | GO:0010269 | response to selenium ion(GO:0010269) |
| 0.1 | 0.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.7 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 | 0.2 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.1 | 0.1 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.1 | 0.6 | GO:0097205 | renal filtration(GO:0097205) |
| 0.1 | 0.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.1 | 1.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 0.8 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.1 | 0.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.1 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 | 0.1 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.1 | 0.6 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.1 | 0.7 | GO:0071467 | cellular response to pH(GO:0071467) |
| 0.1 | 0.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 1.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
| 0.1 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 | 0.5 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.1 | 3.8 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.1 | 0.2 | GO:0003281 | ventricular septum development(GO:0003281) |
| 0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.1 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.2 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.1 | 1.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 | 0.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 1.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.0 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.0 | 0.4 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
| 0.0 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.0 | 0.4 | GO:0045901 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.0 | 0.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.0 | 0.1 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.0 | 0.4 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
| 0.0 | 0.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.0 | 0.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.0 | 0.7 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.0 | 0.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.0 | 0.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.0 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.0 | 0.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.0 | 0.0 | GO:0021561 | facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) |
| 0.0 | 0.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.0 | 0.4 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.0 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.0 | 1.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.0 | 0.2 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.0 | 1.6 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.0 | 0.9 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 0.0 | 1.2 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 1.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 | 0.1 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.0 | 0.0 | GO:0010660 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of muscle cell apoptotic process(GO:0010660) |
| 0.0 | 0.2 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.0 | 0.1 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.0 | 0.0 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.0 | 1.2 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 0.1 | GO:1904587 | response to glycoprotein(GO:1904587) |
| 0.0 | 1.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.0 | 0.5 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.0 | 0.2 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
| 0.0 | 0.2 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.0 | 0.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.0 | 0.2 | GO:0021783 | preganglionic parasympathetic fiber development(GO:0021783) |
| 0.0 | 0.8 | GO:0050779 | RNA destabilization(GO:0050779) |
| 0.0 | 0.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.0 | 0.5 | GO:0006554 | lysine catabolic process(GO:0006554) |
| 0.0 | 0.3 | GO:0006569 | tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
| 0.0 | 1.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.0 | 0.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.0 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.0 | 0.1 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 | 0.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.0 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.0 | 0.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.0 | 0.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
| 0.0 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.0 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.0 | 0.3 | GO:0001821 | histamine secretion(GO:0001821) |
| 0.0 | 0.2 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.0 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.3 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.0 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.0 | 1.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.0 | 0.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 0.0 | 0.6 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.0 | 0.2 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.0 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.0 | 0.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 0.0 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
| 0.0 | 1.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 | 1.3 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
| 0.0 | 0.2 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 | 0.1 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.0 | 0.1 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
| 0.0 | 0.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.0 | 0.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 | 0.2 | GO:0045007 | depurination(GO:0045007) |
| 0.0 | 0.2 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.0 | 0.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.0 | 0.1 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 | 0.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.0 | 0.0 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
| 0.0 | 0.0 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.0 | 0.1 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.0 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.0 | 0.7 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.0 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
| 0.0 | 0.0 | GO:0002573 | myeloid leukocyte differentiation(GO:0002573) |
| 0.0 | 0.2 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.0 | 0.1 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.0 | 0.3 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.0 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 | 0.1 | GO:0050892 | intestinal absorption(GO:0050892) |
| 0.0 | 0.2 | GO:0060602 | branch elongation of an epithelium(GO:0060602) |
| 0.0 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.0 | 2.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.0 | 0.8 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.0 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.0 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 0.2 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
| 0.0 | 0.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.0 | 0.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.0 | 1.1 | GO:0007492 | endoderm development(GO:0007492) |
| 0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 1.7 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
| 0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 | 0.0 | GO:0002664 | regulation of T cell tolerance induction(GO:0002664) |
| 0.0 | 0.2 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
| 0.0 | 0.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.0 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.0 | 0.4 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 | 0.3 | GO:0002293 | alpha-beta T cell activation involved in immune response(GO:0002287) alpha-beta T cell differentiation involved in immune response(GO:0002293) |
| 0.0 | 0.1 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.0 | 0.4 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.0 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.0 | 0.1 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.0 | 1.6 | GO:0001523 | retinoid metabolic process(GO:0001523) |
| 0.0 | 0.1 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.0 | 1.0 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.0 | 0.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 0.1 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
| 0.0 | 0.9 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.0 | 0.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.0 | 0.6 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
| 0.0 | 3.6 | GO:0070268 | cornification(GO:0070268) |
| 0.0 | 0.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 0.0 | 0.1 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 0.0 | 0.2 | GO:0019363 | NADP biosynthetic process(GO:0006741) nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
| 0.0 | 1.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.0 | 0.2 | GO:0001553 | luteinization(GO:0001553) |
| 0.0 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.0 | 0.1 | GO:0043627 | response to estradiol(GO:0032355) response to estrogen(GO:0043627) |
| 0.0 | 0.2 | GO:0022615 | protein import into peroxisome matrix, docking(GO:0016560) protein to membrane docking(GO:0022615) |
| 0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.0 | 2.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.2 | GO:0015755 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.0 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.0 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.0 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) |
| 0.0 | 0.1 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
| 0.0 | 0.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.0 | 1.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.0 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.0 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.0 | 0.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.0 | 0.0 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.0 | 0.1 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.0 | 0.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 | 0.1 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
| 0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.0 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
| 0.0 | 0.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
| 0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 | 0.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.0 | 0.1 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
| 0.0 | 0.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.0 | 0.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.0 | 0.3 | GO:0010259 | multicellular organism aging(GO:0010259) |
| 0.0 | 1.4 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 | 0.1 | GO:0051801 | cytolysis by symbiont of host cells(GO:0001897) hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) cytolysis in other organism involved in symbiotic interaction(GO:0051801) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.0 | 0.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.0 | 0.0 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
| 0.0 | 0.4 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.0 | 0.5 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.0 | 0.2 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.0 | 0.0 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.0 | 0.0 | GO:0046824 | positive regulation of nucleocytoplasmic transport(GO:0046824) |
| 0.0 | 0.1 | GO:0021902 | forebrain neuron fate commitment(GO:0021877) commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 | 0.2 | GO:0009584 | detection of visible light(GO:0009584) |
| 0.0 | 0.0 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.0 | 0.3 | GO:0006903 | vesicle targeting(GO:0006903) |
| 0.0 | 0.2 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 | 1.0 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.0 | 0.0 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.0 | 0.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 | 0.1 | GO:0071599 | otic vesicle development(GO:0071599) |
| 0.0 | 0.5 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 | 0.1 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
| 0.0 | 0.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 0.0 | 0.0 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.0 | 0.0 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
| 0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.0 | 2.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.1 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.0 | 0.0 | GO:0072678 | T cell migration(GO:0072678) |
| 0.0 | 0.1 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.0 | 0.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 | 0.3 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 0.0 | 0.1 | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
| 0.0 | 0.0 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.0 | 0.1 | GO:0043113 | receptor clustering(GO:0043113) |
| 0.0 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.0 | 0.2 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.0 | 0.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.0 | 0.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.0 | 1.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.0 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
| 0.0 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
| 0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.0 | 0.0 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.0 | 0.1 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 | 0.1 | GO:2000209 | regulation of anoikis(GO:2000209) |
| 0.0 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
| 0.0 | 0.1 | GO:0090504 | epiboly(GO:0090504) |
| 0.0 | 0.5 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 3.3 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.0 | 3.2 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
| 0.0 | 0.1 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
| 0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
| 0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.0 | 0.1 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.0 | 0.1 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.0 | 0.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 | 0.2 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.0 | 0.1 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 | 0.2 | GO:0031638 | zymogen activation(GO:0031638) |
| 0.0 | 0.1 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
| 0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.0 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.0 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.1 | GO:0043584 | nose development(GO:0043584) |
| 0.0 | 0.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 | 0.1 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 | 0.0 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.0 | 0.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.0 | 0.0 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.0 | 0.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
| 0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 | 0.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.0 | 0.0 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.0 | 0.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.0 | 0.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 0.0 | 0.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
| 0.0 | 0.1 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.0 | 0.0 | GO:0007231 | osmosensory signaling pathway(GO:0007231) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 | 0.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
| 0.0 | 0.0 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
| 0.0 | 0.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 | 0.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.0 | 0.0 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 | 0.0 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.0 | 0.0 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
| 0.0 | 0.0 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.0 | 0.0 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 | 0.1 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.0 | 0.0 | GO:0048806 | genitalia development(GO:0048806) |
| 0.0 | 0.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.0 | 0.0 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
| 0.0 | 0.0 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 0.0 | 0.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.0 | 0.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.0 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 | 0.1 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 | 0.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 | 0.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 | 0.2 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
| 0.0 | 0.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.0 | 0.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 | 0.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 | 0.1 | GO:0044236 | multicellular organism metabolic process(GO:0044236) |
| 0.0 | 0.0 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 22.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 1.4 | 1.4 | GO:0000806 | Y chromosome(GO:0000806) |
| 1.2 | 1.2 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 1.0 | 4.2 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 1.0 | 8.3 | GO:0070876 | SOSS complex(GO:0070876) |
| 1.0 | 9.0 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 1.0 | 2.9 | GO:1990032 | parallel fiber(GO:1990032) |
| 1.0 | 3.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.9 | 2.7 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.9 | 3.4 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.8 | 6.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.7 | 0.7 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.7 | 5.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.7 | 7.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.7 | 19.9 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.7 | 8.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.7 | 1.3 | GO:0030135 | coated vesicle(GO:0030135) |
| 0.6 | 1.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.6 | 4.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.6 | 5.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.6 | 1.8 | GO:0005608 | laminin-3 complex(GO:0005608) |
| 0.6 | 4.7 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.6 | 0.6 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.6 | 1.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.5 | 3.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.5 | 3.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.5 | 1.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.5 | 13.4 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.5 | 7.8 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.5 | 6.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.5 | 19.8 | GO:0030057 | desmosome(GO:0030057) |
| 0.5 | 1.4 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.5 | 1.4 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.5 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
| 0.4 | 2.2 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.4 | 1.3 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.4 | 1.7 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.4 | 1.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.4 | 3.8 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.4 | 3.4 | GO:0071203 | WASH complex(GO:0071203) |
| 0.4 | 2.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.4 | 1.7 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.4 | 5.8 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.4 | 1.2 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.4 | 1.2 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.4 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.4 | 1.2 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.4 | 3.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.4 | 4.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.4 | 1.2 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.4 | 11.0 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.4 | 1.2 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.4 | 2.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.4 | 6.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.4 | 15.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.4 | 1.1 | GO:0030689 | Noc complex(GO:0030689) |
| 0.4 | 6.0 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.4 | 3.0 | GO:0070695 | FHF complex(GO:0070695) |
| 0.4 | 2.6 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.4 | 1.1 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.4 | 4.6 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.4 | 4.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.4 | 0.7 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.3 | 1.7 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.3 | 1.4 | GO:0060187 | cell pole(GO:0060187) |
| 0.3 | 0.7 | GO:0042581 | specific granule(GO:0042581) |
| 0.3 | 2.0 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.3 | 0.3 | GO:0042025 | host cell nucleus(GO:0042025) |
| 0.3 | 1.7 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.3 | 3.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.3 | 2.9 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.3 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.3 | 1.3 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.3 | 5.9 | GO:0031045 | dense core granule(GO:0031045) |
| 0.3 | 2.4 | GO:0031415 | NatA complex(GO:0031415) |
| 0.3 | 3.3 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.3 | 2.7 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.3 | 1.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.3 | 1.2 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.3 | 3.2 | GO:0016589 | NURF complex(GO:0016589) |
| 0.3 | 2.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.3 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.3 | 3.7 | GO:0045179 | apical cortex(GO:0045179) |
| 0.3 | 1.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.3 | 2.0 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.3 | 3.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.3 | 2.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.3 | 0.8 | GO:0031213 | RSF complex(GO:0031213) |
| 0.3 | 0.8 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.3 | 0.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.3 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.3 | 2.8 | GO:0043219 | lateral loop(GO:0043219) |
| 0.3 | 1.5 | GO:0044308 | axonal spine(GO:0044308) |
| 0.3 | 0.8 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.3 | 1.0 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.3 | 4.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.3 | 3.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.3 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.2 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.2 | 0.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.2 | 0.2 | GO:0005901 | caveola(GO:0005901) |
| 0.2 | 2.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.2 | 3.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.2 | 2.4 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.2 | 2.8 | GO:0043203 | axon hillock(GO:0043203) |
| 0.2 | 0.9 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.2 | 0.5 | GO:0071547 | piP-body(GO:0071547) |
| 0.2 | 1.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.2 | 1.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.2 | 1.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.2 | 2.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.2 | 2.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.2 | 42.1 | GO:0016605 | PML body(GO:0016605) |
| 0.2 | 1.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.2 | 1.6 | GO:0043235 | receptor complex(GO:0043235) |
| 0.2 | 0.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.2 | 1.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.2 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.2 | 0.2 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.2 | 0.6 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.2 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.2 | 0.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.2 | 5.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 0.8 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.2 | 2.2 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.2 | 0.2 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.2 | 2.2 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.2 | 16.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.2 | 14.7 | GO:0002102 | podosome(GO:0002102) |
| 0.2 | 2.1 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.2 | 0.6 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.2 | 5.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.2 | 0.9 | GO:0030673 | axolemma(GO:0030673) |
| 0.2 | 5.8 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 5.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.2 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.2 | 2.4 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.2 | 0.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 1.8 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.2 | 1.3 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.2 | 1.1 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.2 | 2.7 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 1.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.2 | 1.4 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.2 | 0.7 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.2 | 0.2 | GO:0042641 | actomyosin(GO:0042641) |
| 0.2 | 0.7 | GO:0031592 | centrosomal corona(GO:0031592) |
| 0.2 | 1.4 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.2 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.2 | 0.5 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.2 | 12.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.2 | 1.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.2 | 2.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.2 | 1.0 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.2 | 0.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.2 | 0.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.2 | 1.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.2 | 0.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.2 | 0.5 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 0.2 | 2.3 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.2 | 4.9 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.2 | 0.6 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.2 | 4.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.2 | 2.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.2 | 0.3 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.1 | 18.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 1.6 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 0.9 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.1 | 2.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 2.4 | GO:0016234 | inclusion body(GO:0016234) |
| 0.1 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 0.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.1 | 1.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.1 | 1.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 0.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 1.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 1.0 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.1 | 0.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.1 | 0.7 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.1 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.1 | 2.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.1 | 25.6 | GO:0070160 | occluding junction(GO:0070160) |
| 0.1 | 1.3 | GO:0097413 | Lewy body(GO:0097413) |
| 0.1 | 0.1 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.1 | 0.5 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.1 | 3.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 0.1 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.1 | 0.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.1 | 0.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.1 | 1.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 3.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 4.1 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.1 | 1.3 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.1 | 3.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.1 | 1.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 0.6 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.1 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.1 | 3.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 1.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 0.9 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 0.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.1 | 1.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 0.6 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.1 | 0.4 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.1 | 0.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.1 | 3.1 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.1 | 2.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.1 | 0.5 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.1 | 2.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 1.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.1 | 3.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 1.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 4.5 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.1 | 2.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 11.8 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 3.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 0.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 0.5 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 0.1 | 0.6 | GO:0071546 | pi-body(GO:0071546) |
| 0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
| 0.1 | 0.3 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.1 | 1.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 0.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.1 | 1.0 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.1 | 1.2 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 2.8 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 1.3 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.1 | 1.2 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 2.1 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 33.6 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.1 | 2.3 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 0.1 | 6.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 2.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 0.1 | GO:0043614 | multi-eIF complex(GO:0043614) |
| 0.1 | 1.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 1.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.1 | 0.1 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.1 | 0.3 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.1 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 2.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.1 | 25.6 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.1 | 0.6 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.1 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 0.8 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 0.7 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 11.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.1 | 12.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.1 | 19.0 | GO:0030018 | Z disc(GO:0030018) |
| 0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 2.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 0.4 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.1 | 3.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.1 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 0.3 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.1 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.1 | 0.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.1 | 3.6 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 5.4 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.1 | 0.2 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.1 | 0.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.1 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 0.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.1 | 1.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.1 | 0.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 0.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.1 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.1 | 1.7 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.1 | 1.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.1 | 7.1 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.1 | 0.4 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.1 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 0.2 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.1 | 0.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.1 | 0.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.1 | 0.4 | GO:0034448 | EGO complex(GO:0034448) |
| 0.1 | 14.7 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 5.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.1 | 0.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 0.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 0.1 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
| 0.1 | 0.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.1 | 0.3 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.1 | 1.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 0.2 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.1 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 0.1 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.1 | 0.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.1 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 0.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 0.5 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.1 | 0.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.1 | 0.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.1 | 10.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 1.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.1 | 0.2 | GO:0001534 | radial spoke(GO:0001534) |
| 0.1 | 1.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 0.2 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 0.2 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.1 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.1 | 0.2 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.1 | 0.3 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 0.4 | GO:0031430 | M band(GO:0031430) |
| 0.1 | 1.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 0.4 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.1 | 0.1 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 0.1 | 0.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 1.4 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 0.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 0.2 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.1 | 1.2 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.9 | GO:0090543 | Flemming body(GO:0090543) |
| 0.1 | 0.6 | GO:0070187 | telosome(GO:0070187) |
| 0.1 | 0.3 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.1 | 0.2 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.1 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.1 | 1.4 | GO:0012506 | vesicle membrane(GO:0012506) |
| 0.0 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.0 | 0.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.0 | 0.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.0 | 0.3 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.0 | 0.6 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 0.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 5.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.6 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.0 | 0.7 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.0 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.0 | 2.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 1.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.0 | 3.4 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.0 | 4.1 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.0 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.9 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.0 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.0 | 2.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.0 | 0.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.0 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.0 | 1.8 | GO:0030286 | dynein complex(GO:0030286) |
| 0.0 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.0 | 4.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 0.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.0 | 0.1 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.0 | 0.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.0 | 0.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.0 | 0.1 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.0 | 0.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 0.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.0 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.0 | 0.9 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.0 | 1.0 | GO:0031514 | motile cilium(GO:0031514) |
| 0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.0 | 0.1 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.0 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.0 | 0.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.0 | 0.1 | GO:0030684 | preribosome(GO:0030684) |
| 0.0 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.0 | 3.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 0.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.0 | 2.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.0 | 0.1 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.0 | 0.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.0 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.0 | 0.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 2.4 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.0 | 1.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 4.2 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.0 | 0.3 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.0 | 0.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.0 | 0.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 2.9 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 0.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.0 | 2.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.0 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.0 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.0 | 0.4 | GO:0000786 | nucleosome(GO:0000786) |
| 0.0 | 0.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.0 | 0.1 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 0.0 | 0.0 | GO:0001740 | X chromosome(GO:0000805) Barr body(GO:0001740) |
| 0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.0 | 2.0 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.0 | 0.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 1.4 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.0 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
| 0.0 | 0.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.0 | 7.1 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.0 | 1.2 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 1.5 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 0.5 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 0.0 | 0.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 0.0 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 0.4 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.0 | 0.0 | GO:0070702 | inner mucus layer(GO:0070702) outer mucus layer(GO:0070703) |
| 0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 0.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.0 | 0.8 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.0 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 11.7 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 1.9 | 13.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 1.5 | 7.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 1.4 | 14.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 1.3 | 28.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 1.1 | 3.4 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 1.1 | 4.4 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 1.1 | 13.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 1.1 | 3.2 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 1.0 | 1.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.9 | 5.6 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.9 | 12.7 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.9 | 2.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.9 | 11.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.9 | 8.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.8 | 3.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.8 | 12.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.8 | 0.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.8 | 4.1 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.8 | 4.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.8 | 1.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.8 | 30.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.8 | 2.4 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 0.8 | 14.8 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.8 | 3.8 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.8 | 4.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.7 | 4.4 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.7 | 2.2 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.7 | 2.2 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.7 | 2.8 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.7 | 2.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.7 | 10.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.7 | 2.1 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.7 | 1.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.7 | 3.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.7 | 2.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.6 | 0.6 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.6 | 3.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.6 | 6.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.6 | 7.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.6 | 1.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.6 | 1.8 | GO:0035643 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
| 0.6 | 1.8 | GO:0030626 | U12 snRNA binding(GO:0030626) |
| 0.6 | 4.7 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 0.6 | 2.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.6 | 5.2 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.6 | 5.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.6 | 2.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.6 | 4.0 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.6 | 12.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.6 | 10.2 | GO:0015250 | water channel activity(GO:0015250) |
| 0.6 | 2.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.6 | 2.8 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.5 | 1.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.5 | 1.6 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.5 | 1.6 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 0.5 | 2.1 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.5 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.5 | 4.5 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.5 | 4.0 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.5 | 0.5 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.5 | 2.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.5 | 2.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.5 | 1.5 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 0.5 | 4.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.5 | 4.3 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.5 | 3.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
| 0.5 | 4.2 | GO:0030546 | receptor activator activity(GO:0030546) |
| 0.5 | 2.8 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.5 | 4.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.5 | 2.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.5 | 3.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.5 | 3.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.5 | 3.2 | GO:0043426 | MRF binding(GO:0043426) |
| 0.5 | 2.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.5 | 4.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.5 | 2.3 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.4 | 1.8 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.4 | 3.6 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.4 | 1.8 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.4 | 1.3 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.4 | 7.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.4 | 1.8 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.4 | 2.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.4 | 4.0 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.4 | 1.8 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.4 | 3.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.4 | 2.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.4 | 1.7 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.4 | 1.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.4 | 1.3 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
| 0.4 | 1.3 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.4 | 2.1 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.4 | 2.5 | GO:0052842 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.4 | 3.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.4 | 2.9 | GO:0042806 | fucose binding(GO:0042806) |
| 0.4 | 14.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.4 | 1.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.4 | 1.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.4 | 2.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.4 | 0.4 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.4 | 7.7 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.4 | 2.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.4 | 1.6 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 0.4 | 1.2 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.4 | 8.6 | GO:0048185 | activin binding(GO:0048185) |
| 0.4 | 3.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.4 | 3.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.4 | 18.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.4 | 1.5 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.4 | 1.5 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.4 | 4.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.4 | 2.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.4 | 1.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.4 | 4.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.4 | 1.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.4 | 1.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.4 | 2.2 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.4 | 2.1 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.4 | 2.5 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.4 | 4.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.4 | 1.4 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.4 | 1.1 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.4 | 8.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.3 | 1.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.3 | 1.7 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.3 | 1.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.3 | 1.0 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.3 | 5.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.3 | 1.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.3 | 2.0 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.3 | 1.3 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.3 | 3.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.3 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.3 | 1.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.3 | 2.0 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.3 | 4.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.3 | 1.6 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.3 | 4.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.3 | 2.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.3 | 1.0 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.3 | 1.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.3 | 4.9 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.3 | 2.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.3 | 2.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.3 | 0.6 | GO:0004096 | catalase activity(GO:0004096) |
| 0.3 | 4.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.3 | 13.5 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.3 | 2.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.3 | 4.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.3 | 0.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.3 | 1.6 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.3 | 2.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.3 | 2.2 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.3 | 4.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.3 | 3.4 | GO:0031386 | protein tag(GO:0031386) |
| 0.3 | 15.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.3 | 1.2 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.3 | 0.9 | GO:0004040 | amidase activity(GO:0004040) |
| 0.3 | 6.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.3 | 2.1 | GO:0046979 | TAP2 binding(GO:0046979) |
| 0.3 | 1.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.3 | 0.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.3 | 1.2 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.3 | 0.9 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.3 | 0.9 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.3 | 4.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.3 | 7.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.3 | 0.3 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.3 | 0.9 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.3 | 1.7 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.3 | 0.9 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.3 | 2.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.3 | 0.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.3 | 5.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.3 | 1.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.3 | 0.6 | GO:0043394 | proteoglycan binding(GO:0043394) heparan sulfate proteoglycan binding(GO:0043395) |
| 0.3 | 1.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.3 | 2.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.3 | 8.6 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.3 | 1.4 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
| 0.3 | 5.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.3 | 1.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.3 | 0.8 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.3 | 3.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.3 | 0.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.3 | 7.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.3 | 2.7 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.3 | 1.1 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 0.3 | 4.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.3 | 1.6 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.3 | 4.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.3 | 0.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.3 | 2.4 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 0.3 | 10.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.3 | 1.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.3 | 1.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.3 | 0.8 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.3 | 0.8 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.3 | 1.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.3 | 3.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.3 | 1.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.3 | 1.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.3 | 1.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.3 | 0.8 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.3 | 1.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.3 | 0.8 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.3 | 0.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.3 | 1.0 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.3 | 0.8 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 0.3 | 1.3 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.2 | 2.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.2 | 0.7 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
| 0.2 | 6.1 | GO:0019841 | retinol binding(GO:0019841) |
| 0.2 | 1.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.2 | 5.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.2 | 1.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.2 | 3.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.2 | 13.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.2 | 0.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.2 | 1.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.2 | 2.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.2 | 1.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 3.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.2 | 0.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.2 | 3.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.2 | 0.7 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.2 | 1.9 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.2 | 0.7 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.2 | 3.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.2 | 2.5 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.2 | 1.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.2 | 2.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.2 | 0.9 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.2 | 0.7 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.2 | 1.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.2 | 1.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.2 | 7.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.2 | 3.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.2 | 2.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.2 | 2.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.2 | 5.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.2 | 1.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.2 | 0.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.2 | 0.9 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.2 | 0.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.2 | 1.5 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.2 | 32.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.2 | 1.3 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.2 | 1.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.2 | 3.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.2 | 0.6 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.2 | 11.0 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 0.8 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 0.2 | 0.6 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.2 | 1.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.2 | 0.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.2 | 3.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.2 | 1.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.2 | 1.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 8.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.2 | 4.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.2 | 5.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 2.2 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.2 | 1.0 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.2 | 0.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.2 | 0.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.2 | 2.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 2.0 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.2 | 0.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.2 | 6.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.2 | 1.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.2 | 0.6 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.2 | 1.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.2 | 57.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.2 | 2.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.2 | 1.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.2 | 5.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.2 | 19.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.2 | 5.9 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.2 | 0.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.2 | 0.2 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
| 0.2 | 0.6 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.2 | 5.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.2 | 0.9 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.2 | 0.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.2 | 3.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.2 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.2 | 6.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.2 | 4.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.2 | 0.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 0.2 | 5.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.2 | 5.8 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 1.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.2 | 1.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.2 | 1.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
| 0.2 | 1.4 | GO:0046790 | virion binding(GO:0046790) |
| 0.2 | 0.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.2 | 1.9 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.2 | 0.3 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 0.2 | 0.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.2 | 1.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.2 | 2.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.2 | 21.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.2 | 2.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.2 | 2.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 1.8 | GO:0015288 | porin activity(GO:0015288) |
| 0.2 | 1.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.2 | 1.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.2 | 0.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.2 | 2.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.2 | 0.9 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.2 | 2.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.2 | 4.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.2 | 0.8 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.2 | 0.5 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.2 | 1.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.2 | 2.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.2 | 0.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.1 | 1.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.1 | 1.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.1 | 1.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 0.6 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.1 | 0.4 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
| 0.1 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 1.2 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.1 | 0.6 | GO:0004644 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
| 0.1 | 0.4 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.1 | 0.4 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.1 | 0.4 | GO:0042903 | tubulin deacetylase activity(GO:0042903) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
| 0.1 | 0.4 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.1 | 7.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 1.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.1 | 0.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 3.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 2.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 0.4 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.1 | 2.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.1 | 1.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.1 | 10.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.1 | 2.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 3.9 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 1.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.1 | 0.7 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.1 | 1.0 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.1 | 1.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.1 | 0.5 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.1 | 0.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.1 | 0.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.3 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.1 | 0.4 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.1 | 1.8 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 1.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 1.4 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.1 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.1 | 3.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 1.2 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 3.8 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.1 | 1.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 1.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 0.4 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.1 | 1.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 0.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.1 | 2.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 2.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.1 | 2.1 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.1 | 1.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 2.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 1.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.1 | 1.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.1 | 0.7 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.1 | 1.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 0.6 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.1 | 0.6 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.1 | 2.9 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 1.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.1 | 3.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.1 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
| 0.1 | 0.1 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.1 | 3.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 0.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.1 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.1 | 0.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 0.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 0.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 0.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 2.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 2.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 9.4 | GO:0033558 | protein deacetylase activity(GO:0033558) |
| 0.1 | 0.3 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.1 | 3.2 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 1.5 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 1.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 22.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 1.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 3.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.1 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.1 | 0.4 | GO:0004104 | acetylcholinesterase activity(GO:0003990) cholinesterase activity(GO:0004104) |
| 0.1 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.1 | 3.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 0.7 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 0.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 3.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 0.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.1 | 5.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 0.7 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.1 | 0.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.1 | 3.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 4.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 0.6 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.1 | 2.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 1.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.1 | 0.2 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
| 0.1 | 0.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.1 | 1.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 0.3 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.1 | 2.5 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 1.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 1.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 2.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.1 | 0.4 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.1 | 0.8 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 0.1 | 1.0 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 0.4 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.1 | 0.5 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.1 | 2.1 | GO:0045502 | dynein binding(GO:0045502) |
| 0.1 | 0.3 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.1 | 3.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.1 | 1.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.1 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.1 | 6.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.1 | 0.3 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.1 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 0.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.1 | 0.4 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.1 | 0.2 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.1 | 2.1 | GO:0043236 | laminin binding(GO:0043236) |
| 0.1 | 0.3 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.1 | 0.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.1 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 1.2 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 1.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
| 0.1 | 0.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.1 | 2.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.1 | 0.8 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.1 | 0.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 0.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.1 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.1 | 3.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 0.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.1 | 0.4 | GO:0019863 | IgE binding(GO:0019863) |
| 0.1 | 3.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.1 | 0.5 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.1 | 1.9 | GO:0070008 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 2.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 0.2 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.1 | 0.8 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.1 | 0.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 0.1 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.1 | 1.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.1 | 1.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.1 | 0.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 1.0 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 1.6 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) TFIIB-class transcription factor binding(GO:0001093) |
| 0.1 | 0.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.1 | 0.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.1 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
| 0.1 | 1.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.1 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.1 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 0.1 | 1.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.1 | 0.4 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.1 | 0.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.1 | 0.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.1 | 1.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.1 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
| 0.1 | 0.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.1 | 14.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 1.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 2.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 0.6 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.1 | 2.0 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.1 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 0.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.1 | 7.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.1 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 0.1 | 3.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 1.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 0.3 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 0.1 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.1 | 0.1 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.1 | 0.4 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.1 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.1 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
| 0.1 | 0.5 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.1 | 0.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.1 | 0.3 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.1 | 0.3 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.1 | 0.2 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.1 | 1.5 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.9 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.1 | 1.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.1 | 0.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.1 | 0.2 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.1 | 0.2 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
| 0.1 | 1.1 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.1 | 2.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 1.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 0.2 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
| 0.1 | 0.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 0.2 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.1 | 0.4 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.1 | 0.2 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.1 | 0.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.1 | 0.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.1 | 3.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 0.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.1 | 2.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 0.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
| 0.1 | 0.1 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 7.7 | GO:0002020 | protease binding(GO:0002020) |
| 0.1 | 0.2 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.1 | 1.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 1.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 1.0 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.1 | 2.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.1 | 0.4 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.1 | 0.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.1 | 0.5 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 0.4 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.1 | 0.3 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.1 | 0.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.1 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.1 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
| 0.1 | 0.4 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 0.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 0.4 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 5.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 1.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.1 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.2 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.1 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.0 | 0.2 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.0 | 0.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 1.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.0 | 0.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.0 | 0.1 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.0 | 0.6 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.0 | 0.2 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.0 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.0 | 4.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
| 0.0 | 0.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.0 | 0.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.0 | 0.3 | GO:0016918 | retinal binding(GO:0016918) |
| 0.0 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.0 | 0.1 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
| 0.0 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.0 | 0.8 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 0.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 3.4 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.0 | 0.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.0 | 0.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.0 | 1.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 1.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.0 | 0.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.0 | 0.5 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.0 | 0.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.0 | 0.2 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.0 | 0.1 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.0 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.0 | 0.2 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.0 | 0.2 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
| 0.0 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.0 | 0.1 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.0 | 0.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.0 | 0.2 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.0 | 0.1 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.0 | 0.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.1 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.0 | 1.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.0 | 0.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.0 | 0.1 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.0 | 0.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 0.6 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
| 0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.0 | 3.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.6 | GO:0001848 | complement binding(GO:0001848) |
| 0.0 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
| 0.0 | 0.7 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.0 | 0.1 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.0 | 0.1 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.0 | 0.3 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 0.0 | 0.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 0.0 | 9.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.0 | 1.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.0 | 0.1 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.0 | 0.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.0 | 0.6 | GO:0051020 | GTPase binding(GO:0051020) |
| 0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.0 | 0.1 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.0 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 0.2 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.0 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
| 0.0 | 0.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 47.2 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
| 0.0 | 0.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.0 | 0.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.0 | 0.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.0 | 0.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.0 | 0.0 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 0.0 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.0 | 0.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
| 0.0 | 0.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.0 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.0 | 0.1 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.0 | 0.1 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.0 | 0.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.0 | 0.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.0 | 0.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.0 | 0.0 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.0 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.0 | 0.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 1.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.0 | 0.1 | GO:0086039 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 0.0 | 0.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.0 | 0.1 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.0 | 0.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
| 0.0 | 0.0 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.0 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.0 | 0.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.0 | 0.1 | GO:0016295 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
| 0.0 | 0.0 | GO:0004803 | transposase activity(GO:0004803) |
| 0.0 | 0.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.0 | 0.0 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.0 | 0.0 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.0 | 0.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.0 | 1.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.0 | 1.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.0 | GO:0016992 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
| 0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 5.1 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.0 | 0.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.0 | 0.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.0 | 0.3 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.0 | 0.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.0 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 1.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.4 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
| 0.0 | 0.0 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.0 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.0 | 0.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.0 | 0.0 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
| 0.0 | 0.0 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.0 | 0.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 1.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.8 | 1.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.7 | 18.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.7 | 1.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.6 | 17.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.5 | 1.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.4 | 10.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.4 | 4.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.4 | 2.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.3 | 4.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.3 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.3 | 2.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.3 | 4.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.3 | 24.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.3 | 2.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.3 | 19.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.3 | 23.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.3 | 4.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.2 | 13.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 8.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.2 | 7.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.2 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.2 | 10.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 10.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.2 | 15.7 | PID FGF PATHWAY | FGF signaling pathway |
| 0.2 | 3.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 1.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.2 | 9.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.2 | 1.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.2 | 3.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.2 | 45.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.2 | 11.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.2 | 10.8 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.2 | 13.9 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 3.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.2 | 5.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 6.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 8.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 2.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 0.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.1 | 0.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 12.7 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.1 | 3.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 2.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 0.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.1 | 0.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 2.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 9.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 7.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 5.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 27.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 1.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 1.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.1 | 2.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 2.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 4.8 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 0.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 1.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 1.3 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 1.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 1.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 2.6 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 2.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 3.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 1.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 3.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 6.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 24.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 1.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 3.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 2.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.1 | 3.8 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 4.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 1.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 1.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 2.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.1 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 1.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 1.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 1.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 0.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.1 | 1.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 0.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 2.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 0.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 0.6 | ST ADRENERGIC | Adrenergic Pathway |
| 0.0 | 5.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 1.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 4.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 14.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 1.0 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 3.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 1.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 0.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 0.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.0 | 1.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 0.9 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 1.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 1.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 1.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
| 0.0 | 1.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.0 | 0.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 0.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.0 | 0.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 1.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 3.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.7 | 16.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.6 | 13.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.6 | 10.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.5 | 8.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.5 | 5.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.5 | 1.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.5 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.4 | 10.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.4 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.4 | 15.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.4 | 5.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.3 | 4.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.3 | 4.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.3 | 8.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.3 | 3.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.3 | 0.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.3 | 3.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.3 | 12.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.3 | 7.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.3 | 6.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.3 | 0.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.2 | 5.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.2 | 1.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.2 | 1.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.2 | 17.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.2 | 13.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.2 | 0.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.2 | 26.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.2 | 5.7 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
| 0.2 | 2.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.2 | 4.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.2 | 5.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.2 | 17.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.2 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.2 | 3.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 4.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.2 | 2.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.2 | 11.3 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
| 0.2 | 9.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.2 | 6.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 4.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.2 | 3.8 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.2 | 2.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.2 | 7.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.2 | 1.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.2 | 3.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 1.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.2 | 4.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.2 | 3.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.2 | 0.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.2 | 5.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.2 | 4.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.2 | 5.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.2 | 2.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 0.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.1 | 6.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 2.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 3.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 5.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.1 | 3.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.1 | 1.5 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.1 | 8.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.1 | 7.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 4.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 3.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 2.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 1.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.1 | 1.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 2.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 11.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 2.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.1 | 5.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 2.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.1 | 1.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.1 | 7.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 1.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.1 | 0.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 5.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 7.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 3.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 3.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 7.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.1 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 2.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.1 | 2.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 6.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 2.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 5.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 3.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 3.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.1 | 3.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.1 | 1.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.1 | 0.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.1 | 16.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.1 | 2.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 1.7 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
| 0.1 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 4.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 3.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.1 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.1 | 1.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.1 | 1.1 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
| 0.1 | 2.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.1 | 9.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 0.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 2.4 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
| 0.1 | 5.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.1 | 5.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 0.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
| 0.1 | 1.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.1 | 2.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 1.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 2.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 0.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.0 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.0 | 0.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 1.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.0 | 0.4 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 0.0 | 1.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.0 | 5.1 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
| 0.0 | 2.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 2.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.0 | 0.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.0 | 19.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.0 | 0.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 1.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.0 | 1.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 2.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.7 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
| 0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 1.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.0 | 0.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.0 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.0 | 0.7 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.0 | 0.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.0 | 1.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.0 | 0.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.0 | 2.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.0 | 2.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.0 | 0.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.0 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.0 | 1.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.0 | 0.1 | REACTOME KINESINS | Genes involved in Kinesins |